Advanced Search

Immunology Evaluations

To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.

Sign in | Free Trial | Subscribe | Recommend to Library

New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.

HEADS OF FACULTY

  • Photo of Frederick Alt

    Frederick Alt

    Children's Hospital Boston, Immune Disease Institute, Department of Medicine, HHMI/Children's Hospital Boston/Harvard Medical School/ Immune Disease Institute, USA

  • Photo of Douglas Fearon

    Douglas Fearon

    Wellcome Trust Immunology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK

  • Photo of Philippa Marrack

    Philippa Marrack

    National Jewish Center for Immunology and Respiratory, National Jewish Medical and Research Center, Denver, CO, USA

TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]

14
The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response.

Sanada T, Kim M, Mimuro H, Suzuki M, ..., Gohda J, Inoue J, Mizushima T, Sasakawa C. Nature. 2012 Mar 29; 483(7391):623-6

4 Evaluations, most recent by

Christoph Dehio and Arto Pulliainen, University of Basel, Switzerland. F1000 Microbiology

Past 7 Days

70

New Evaluations

41,955 total

21

New Articles Evaluated

10,841 total

Past 30 Days

INDIVIDUAL SUBSCRIPTIONS

Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or a monthly subscription.

Get a FREE Trial

Start your personal subscription today.

Subscribe for $9.95/month

INSTITUTIONAL SUBSCRIPTIONS

Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.

Recommend to your Librarian

If you are a librarian or informationa manager, you may request an extended free trial for your academic or corporate institution.

Request an Institutional Trial

your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.